Literature DB >> 23257521

The presence of pretreatment cavitations and the bacterial load on smears predict tuberculosis infectivity negative conversion judged on sputum smear or culture.

Nobuyuki Horita1, Naoki Miyazawa, Takashi Yoshiyama, Ryota Kojima, Naoko Omori, Miyo Inoue, Takeshi Kaneko, Yoshiaki Ishigatsubo.   

Abstract

OBJECTIVE: There are no rules to predict the time to infectivity negative conversion based on sputum smear conversion or culture conversion during chemotherapy in smear-positive tuberculosis patients. We aimed to develop and validate rules of sputum smear grades and cavitations in the lungs due to tuberculosis.
METHODS: This study was a retrospective cohort study that consisted of development (n=158, 64 ± 19 years of age) and validation (n=214, 63 ± 20 years of age) steps in different cohorts. We developed a rule with pretreatment smear grades and the existence of cavitations in the lungs due to tuberculosis as independent variables and the duration to infectivity negative conversion as the dependent variable in a Cox hazard model. The smear grade indicating the pretreatment bacterial load was classified into four grades according to the Japanese guidelines. The presence of cavitations was assessed on X-ray. Infectivity conversion was defined according to the criteria of the Japanese Ministry of Health, Labour and Welfare: a patient is currently receiving proper treatment and shows clinical improvement and sputum smears and cultures in any combination are consecutively negative three times.
RESULTS: <DEVELOPMENT> We developed an "Infectivity Conversion Score" classifying each patient with a smear grade of I though IV and assessing the existence of cavitations in the lungs due to tuberculosis. <VALIDATION> The median time to infectivity conversion in the validation cohort was 13, 22, 35 and 50 days for Infectivity Conversion Scores I through IV, respectively (p<0.001).
CONCLUSION: We developed and validated Infectivity Conversion Scores.

Entities:  

Mesh:

Year:  2012        PMID: 23257521     DOI: 10.2169/internalmedicine.51.8585

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  3 in total

1.  HbA1c level cannot predict the treatment outcome of smear-positive non-multi-drug-resistant HIV-negative pulmonary tuberculosis inpatients.

Authors:  Ken Tashiro; Nobuyuki Horita; Kenjiro Nagai; Misako Ikeda; Masaharu Shinkai; Masaki Yamamoto; Takashi Sato; Yu Hara; Hideyuki Nagakura; Yuji Shibata; Hiroki Watanabe; Kentaro Nakashima; Ryota Ushio; Akimichi Nagashima; Atsuya Narita; Nobuaki Kobayashi; Makoto Kudo; Takeshi Kaneko
Journal:  Sci Rep       Date:  2017-04-13       Impact factor: 4.379

2.  The effectiveness of sputum pH analysis in the prediction of response to therapy in patients with pulmonary tuberculosis.

Authors:  Makoto Masuda; Takashi Sato; Kentaro Sakamaki; Makoto Kudo; Takeshi Kaneko; Yoshiaki Ishigatsubo
Journal:  PeerJ       Date:  2015-11-26       Impact factor: 2.984

3.  Correlation of Xpert MTB/RIF with measures to assess Mycobacterium tuberculosis bacillary burden in high HIV burden areas of Southern Africa.

Authors:  Fenella Beynon; Grant Theron; Durval Respeito; Edson Mambuque; Belen Saavedra; Helder Bulo; Sergi Sanz; Keertan Dheda; Alberto L Garcia-Basteiro
Journal:  Sci Rep       Date:  2018-03-26       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.